- Home
- DSU vs TLRY Comparison
DSU vs TLRY Comparison
Compare DSU & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DSU | TLRY |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 594.7M | 570.4M |
| IPO Year | 1998 | 2018 |
Fundamental Metrics
Financial Performance| Metric | DSU | TLRY |
|---|---|---|
| Price | $9.45 | $4.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $72.33 |
| AVG Volume (30 Days) | 280.2K | ★ 4.7M |
| Earning Date | 01-01-0001 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.69 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.79 |
| Revenue Next Year | N/A | $19.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.31 | $0.77 |
| 52 Week High | $10.64 | $15.70 |
Technical Indicators
Market Signals| Indicator | DSU | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 41.93 | 53.66 |
| Support Level | $9.33 | $4.27 |
| Resistance Level | $9.94 | $4.90 |
| Average True Range (ATR) | 0.05 | 0.24 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 17.65 | 53.28 |
Price Performance
Historical ComparisonAbout DSU Blackrock Debt Strategies Fund Inc.
Blackrock Debt Strategies Fund Inc is a closed-end management investment company. Its primary investment objective is to seek to provide current income by investing in a diversified portfolio of U.S. companies debt instruments, including senior and subordinated corporate loans, both secured and unsecured, which are rated in the lower rating categories of the established rating services or unrated debt instruments, which are in the judgment of the investment adviser of equivalent quality. The Fund may invest directly in debt instruments or synthetically through the use of derivatives. The Fund's secondary investment objective is to seek to provide capital appreciation.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.